These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 8042597

  • 21. Transmyocardial fibrinolytic activity in patients with unstable angina pectoris.
    Daniel WC, Meidell RS, Hillis LD, Lange RA.
    Coron Artery Dis; 1996 Jan; 7(1):45-9. PubMed ID: 8773432
    [Abstract] [Full Text] [Related]

  • 22. Mild hyperhomocysteinemia is associated with a decreased fibrinolytic activity in patients after ST-elevation myocardial infarction.
    Speidl WS, Nikfardjam M, Niessner A, Zeiner A, Jordanova N, Zorn G, Maurer G, Schreiber W, Wojta J, Huber K.
    Thromb Res; 2007 Jan; 119(3):331-6. PubMed ID: 16616324
    [Abstract] [Full Text] [Related]

  • 23. The relationship among TAFI, t-PA, PAI-1 and F1 + 2 in type 2 diabetic patients with normoalbuminuria and microalbuminuria.
    Chudý P, Kotuličová D, Staško J, Kubisz P.
    Blood Coagul Fibrinolysis; 2011 Sep; 22(6):493-8. PubMed ID: 21519232
    [Abstract] [Full Text] [Related]

  • 24. Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels in plasma of patients with unstable coronary artery disease and acute myocardial infarction.
    Huber K, Rosc D, Resch I, Schuster E, Glogar DH, Kaindl F, Binder BR.
    Thromb Haemost; 1988 Dec 22; 60(3):372-6. PubMed ID: 3149044
    [Abstract] [Full Text] [Related]

  • 25. Depression of tissue plasminogen activator (t-PA) activity and rise of t-PA inhibition and acute phase reactants in blood of patients with acute myocardial infarction (AMI).
    Gram J, Kluft C, Jespersen J.
    Thromb Haemost; 1987 Oct 28; 58(3):817-21. PubMed ID: 2448888
    [Abstract] [Full Text] [Related]

  • 26. [Fibrinolytic system in patients with myocardial infarction and other coronary disease risk factors].
    Moreno JA, Gálvez MM, Cornudella R, Angós JA, Romero MS, Gutiérrez M.
    Sangre (Barc); 1994 Apr 28; 39(2):111-6. PubMed ID: 8059288
    [Abstract] [Full Text] [Related]

  • 27. [Levels of tissue-type plasminogen activator (T-PA), its inhibitor (PAI-1) and fibrinogen in the blood of patients with type 1 and 2 diabetes mellitus].
    Kvasnicka J, Skrha J, Perusicová J, Maslowská H, Pochopová L.
    Cas Lek Cesk; 1996 Mar 20; 135(6):174-7. PubMed ID: 8681360
    [Abstract] [Full Text] [Related]

  • 28. Impairment of plasma fibrinolysis in young survivors of myocardial infarction with silent ischaemia.
    Grzywacz A, Elikowski W, Psuja P, Zozulińska M, Zawilska K.
    Blood Coagul Fibrinolysis; 1998 Apr 20; 9(3):245-9. PubMed ID: 9663707
    [Abstract] [Full Text] [Related]

  • 29. Interrelationship between coagulant activity and tissue-type plasminogen activator (t-PA) system in acute ischaemic heart disease. Possible role of the endothelium.
    Munkvad S, Jespersen J, Gram J, Kluft C.
    J Intern Med; 1990 Oct 20; 228(4):361-6. PubMed ID: 1702458
    [Abstract] [Full Text] [Related]

  • 30. On the association of elevated tPA/PAI-1 complex and von Willebrand factor with recurrent myocardial infarction.
    Bounameaux H, Kruithof EK.
    Arterioscler Thromb Vasc Biol; 2000 Aug 20; 20(8):1857-9. PubMed ID: 10938004
    [No Abstract] [Full Text] [Related]

  • 31. Fibrinolytic activity in peripheral atherosclerosis in the elderly.
    van der Bom JG, Bots ML, Haverkate F, Meyer P, Hofman A, Grobbee DE, Kluft C.
    Thromb Haemost; 1999 Feb 20; 81(2):275-80. PubMed ID: 10064006
    [Abstract] [Full Text] [Related]

  • 32. [Evaluation of the fibrinolytic system in myocardial infarction].
    Moreno JA, Cornudella R, Gálvez M, Angós JA, Romero S, Gutiérrez M.
    Sangre (Barc); 1994 Feb 20; 39(1):23-7. PubMed ID: 8197514
    [Abstract] [Full Text] [Related]

  • 33. [Plasminogen activators (t-PA and u-PA) and other fibrinolysis parameters in patients with atherosclerosis obliterans and diabetic macroangiopathy].
    Zalewska-Rydzkowska D, Rość D, Ponikowska I, Michalski A, Graczykowska-Koczorowska A, Rydzkowski M.
    Pol Merkur Lekarski; 2001 Nov 20; 11(65):414-7. PubMed ID: 11852811
    [Abstract] [Full Text] [Related]

  • 34. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
    Rość D, Kremplewska-Nalezyta E, Gadomska G, Zastawna E, Michalski A, Drewniak W.
    Med Sci Monit; 2000 Nov 20; 6(4):684-91. PubMed ID: 11208392
    [Abstract] [Full Text] [Related]

  • 35. [Changes in coagulation and fibrinolysis in the patients with coronary heart disease in acute period and effect of drug intervention].
    Jia XQ, Dong CM, Qin J, Zhang L.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Apr 20; 24(4):225-8. PubMed ID: 22464576
    [Abstract] [Full Text] [Related]

  • 36. Fibrinogen, t-PA, and PAI-1 plasma levels in patients with pulmonary hypertension.
    Huber K, Beckmann R, Frank H, Kneussl M, Mlczoch J, Binder BR.
    Am J Respir Crit Care Med; 1994 Oct 20; 150(4):929-33. PubMed ID: 7921465
    [Abstract] [Full Text] [Related]

  • 37. Retained fibrinolytic response and no coagulation activation after acute physical exercise in middle-aged women with previous myocardial infarction.
    Eriksson-Berg M, Egberg N, Eksborg S, Schenck-Gustafsson K.
    Thromb Res; 2002 Mar 15; 105(6):481-6. PubMed ID: 12091046
    [Abstract] [Full Text] [Related]

  • 38. Plasma TAFI and soluble CD40 ligand do not predict reperfusion following thrombolysis for acute myocardial infarction.
    Cruden NL, Graham C, Harding SA, Ludlam CA, Fox KA, Newby DE.
    Thromb Res; 2006 Mar 15; 118(2):189-97. PubMed ID: 16055173
    [Abstract] [Full Text] [Related]

  • 39. Captopril reduced plasminogen activator inhibitor activity in patients with acute myocardial infarction.
    Moriyama Y, Ogawa H, Oshima S, Takazoe K, Honda Y, Hirashima O, Arai H, Sakamoto T, Sumida H, Suefuji H, Kaikita K, Yasue H.
    Jpn Circ J; 1997 Apr 15; 61(4):308-14. PubMed ID: 9152782
    [Abstract] [Full Text] [Related]

  • 40. [A study on the circadian variation of tissue-type plasminogen activator and its rapid inhibitor in patients with coronary heart disease].
    Chen ZY.
    Zhonghua Xin Xue Guan Bing Za Zhi; 1993 Jun 15; 21(3):163-4, 188. PubMed ID: 8243232
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.